KTOV FDA Approval take gains and get out

31 พ.ค. 2018

As expected NASDAQ:KTOV passed the FDA approval time to take some gains and move on to the next one.
finance.yahoo.com/news/fda-approves-kitov-consensi-treatment-174500954.html?.tsrc=rss